Scimplify, a B2B platform specializing in the sourcing and manufacturing of specialty chemicals, has raised $9.5 million in its Series A funding round. The round was led by Omnivore, with participation from Bertelsmann India Investments and existing investors 3one4 Capital and Beenext.
This fresh capital injection will enable Scimplify to enhance its research and development capabilities and extend its operations to additional key markets. The company aims to bolster its offerings and better serve its diverse customer base across multiple industries.
Founded by Salil Srivastava and Sachin Santhosh, Scimplify operates across the entire product lifecycle, from contract research to commercial chemical manufacturing. The company’s platform caters to industries such as pharmaceuticals, personal care, and agrochemicals, providing an end-to-end solution for contract manufacturing of agrochemicals, pharmaceutical APIs, and flavours & fragrances.
Based in Bengaluru, Scimplify faces competition from companies like Atomgrid and Covvalent. Atomgrid recently raised $1.2 million in a seed round led by Merak Ventures, while Covvalent secured $4.3 million in a round led by Nexus Ventures.
With the new funding, Scimplify is poised to strengthen its market position, drive innovation, and expand its footprint in the speciality chemicals industry.
